Anzeige
Mehr »
Lynx Broker
Login
Mittwoch, 23.10.2019 Börsentäglich über 12.000 News von 614 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2ADY1 ISIN: SE0007789409 Ticker-Symbol: 7XB 
Berlin
23.10.19
18:46 Uhr
2,770 Euro
-0,080
-2,81 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
XBRANE BIOPHARMA AB Chart 1 Jahr
5-Tage-Chart
XBRANE BIOPHARMA AB 5-Tage-Chart

Aktuelle News zur XBRANE BIOPHARMA Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
XBRANE BIOPHARMA Aktien jetzt im kostenlosen Demokonto handeln!
23.09.Nasdaq Nordic: Nasdaq Stockholm Welcomes Xbrane Biopharma AB to The Main Market180Stockholm, September 23, 2019 - Nasdaq (Nasdaq: NDAQ) announces that the trading in Xbrane Biopharma AB's shares (short name: XBRANE) will commence today on the Nasdaq Stockholm main market. Xbrane...
► Artikel lesen
19.09.Nasdaq Stockholm AB: Listing of Xbrane Biopharma AB on Nasdaq Stockholm (137/19)158On request of Xbrane Biopharma AB, company registration number 556749-2375, Nasdaq Stockholm has admitted the company's shares tot trading on Nasdaq Stockholm with effect from September 23, 2019. The...
► Artikel lesen
17.09.Nasdaq Stockholm AB: Listing of Xbrane Biopharma AB on Nasdaq Stockholm (134/19)230Nasdaq Stockholm AB has assessed that Xbrane Biopharma AB, company registration number 556749-2375, fulfills Nasdaq Stockholm's listing requirements. Provided that Xbrane Biopharma AB applies for admission...
► Artikel lesen
17.09.Nasdaq Stockholm AB: Last day of trading in XBrane BioPharma AB (321/19)165At the request of XBrane BioPharma AB, the trading in company's shares on Nasdaq First North Growth Market is to cease. As from September 23, 2019, the shares will be listed on Nasdaq Stockholm. The...
► Artikel lesen
27.06.Nasdaq Stockholm AB: Trading in subscription rights (TR) and paid subscription shares (BTA) in Xbrane Biopharma AB (244/19)49As from June 28, 2019 subscription rights issued by Xbrane Biopharma AB will be traded on First North. Trading in subscription rights will continue until July 10, 2019. Instrument: TR ...
► Artikel lesen
29.04.Xbrane Biopharma - Mammalian movement64Xbrane, a leading innovative biosimilar development company, is moving into mammalian cell culture with announced plans for Xdivane, a biosimilar of the immunoncology blockbuster Opdivo (nivolumab,...
► Artikel lesen
12.04.Nasdaq Stockholm AB: Last day of trading in paid subscription shares (BTA) of Xbrane Biopharma AB (publ) (136/19)61Trading in Xbrane Biopharma AB (publ) paid subscription shares is to cease with immediate effect. The last trading day was today, April 12, 2019. Short name: XBRANE BTA --------------------------- ISIN...
► Artikel lesen
11.03.Nasdaq Stockholm AB: Trading in subscription rights and paid subscription shares in Xbrane Biopharma AB (publ) (78/19)51As from March 12, 2019, Subscription rights issued by Xbrane Biopharma AB (publ) will be traded on First North. Trading will continue until March 21, 2019. Instrument: TR ...
► Artikel lesen
04.03.Xbrane Biopharma - Biosimilar focus with Phase III trial about to start36Edison Investment Research - Pharmaceuticals & healthcare - Xbrane Biopharma: Xbrane now focuses on developing high-margin biosimilar products with Xlucane, its Lucentis biosimilar, as the lead product....
► Artikel lesen
23.11.18Edison issues outlook on Xbrane Biopharma (XBRANE)71Dow Jones received a payment from EQS/DGAP to publish this press release. Edison Investment Research Limited Edison issues outlook on Xbrane Biopharma (XBRANE) 23-Nov-2018 / 13:37...
► Artikel lesen
10 Nachrichten in den letzten 12 Monaten

Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1